US · AKAN
Akanda Corp.
- Sector
- Healthcare · Drug Manufacturers - Specialty & Generic
- Headquarters
- New Romney, ON TN28 8XU
- Website
- akandacorp.com
Price · as of 2024-12-31
$57.09
Market cap 151.47K
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $99.96 | +75.09% |
| Intrinsic Value(DCF) | $10.00 | -82.48% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $198.15 | +247.08% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | $92,500.00 | $41,459.51 | $517,428.67 | $0.00 | $0.00 |
| 2022 | $1,525.00 | $2,658.46 | $233,679,301.40 | $0.00 | $0.00 |
| 2023 | $225.00 | $2,353.31 | $10.42 | $0.00 | $530.14 |
| 2024 | $25.00 | $99.96 | $0.57 | $0.00 | $198.15 |
AI valuation
Our deep-learning model estimates Akanda Corp.'s (AKAN) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $99.96
- Current price
- $57.09
- AI upside
- +75.09%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$10.00
-82.48% upside
Graham-Dodd
—
— upside
Graham Formula
$198.15
+247.08% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| AKAN | Akanda Corp. | $57.09 | 151.47K | +75% | -82% | — | +247% | -6.36 | 6.09 | 31.14 | -7.45 | — | 6.11 | 24.91% | -523.80% | -489.57% | -1830.03% | -998.53% | -48.90% | 0.08 | -43.78 | 1.39 | 1.28 | 1.15 | -9355.00% | -6127.00% | 30467.00% | -23.33% | -1.09 | -1384.96% | 0.00% | 0.00% | 28.41% | -5.15 | -3.71 | 26.97 | -7.37 |
| BBLG | Bone Biologics Corporatio… | $1.15 | 2.07M | — | — | — | — | -1.86 | 2.19 | — | 40.32 | — | 2.19 | 0.00% | — | — | -128.71% | -22020.98% | -108.23% | 0.00 | — | 10.22 | 8.80 | -31.03 | -8580.00% | — | -5683.00% | -53.95% | -10.92 | -21530.04% | 42.02% | -78.10% | 45.92% | -1.02 | -1.05 | — | -21.20 |
| GCTK | GlucoTrack, Inc. | $1.55 | 879.56K | — | — | — | — | -0.36 | -0.63 | — | -0.13 | — | -0.63 | 0.00% | — | — | 461.02% | 149.59% | -417.03% | -0.02 | -24.95 | 4.52 | 4.41 | 0.24 | -25864.00% | — | 9204.00% | -152.95% | -9.80 | 129.51% | 0.00% | 0.00% | 12.80% | -0.20 | -0.23 | — | -38.18 |
| GNPX | Genprex, Inc. | $2.00 | 3.26M | — | — | — | — | -0.06 | 0.84 | — | 0.01 | — | 0.84 | 0.00% | — | — | -467.24% | -6073.62% | -285.38% | 0.00 | — | 0.83 | 0.64 | 0.08 | -7633.00% | — | -3088.00% | -1259.09% | -6.85 | -4919.06% | 20346.13% | -1312.70% | 20346.13% | 0.01 | 0.01 | — | -69.29 |
| HSCS | HeartSciences Inc. | $2.79 | 6.25M | +699% | -40% | — | +21,742% | -0.45 | 19.02 | 897.28 | -0.71 | — | -2.77 | -2884.71% | -192013.13% | -201499.52% | -233.04% | -360.16% | -127.72% | 14.55 | -16.69 | 0.59 | 0.30 | -0.23 | -5016.00% | -7661.00% | 2014.00% | -190.70% | -2.00 | -320.95% | 0.00% | 0.00% | 0.00% | -0.69 | -0.78 | 1331.10 | -31.62 |
| IMCC | IM Cannabis Corp. | $0.68 | 2.1M | +52,536% | +13% | — | — | -0.54 | 1.20 | 0.12 | -3.82 | -39.70 | -1.32 | 15.64% | -18.94% | -19.59% | -119.43% | -38.57% | -26.75% | 3.44 | -2.29 | 0.67 | 0.50 | -2.79 | 135.00% | 1071.00% | -8576.00% | -19.57% | -0.03 | -5.05% | 0.00% | 0.00% | 0.00% | -2.29 | -19.02 | 0.43 | -8.98 |
| JAGX | Jaguar Health, Inc. | $0.89 | 1.93M | +7,724% | +550% | — | — | -0.11 | 0.58 | 0.36 | -0.89 | — | -0.38 | 83.27% | -263.76% | -329.30% | -637.50% | -86.37% | -74.93% | 5.01 | -133.47 | 1.63 | 0.49 | -0.78 | -9513.00% | 1975.00% | -1091.00% | -697.04% | -1.49 | -82.96% | 0.00% | 0.00% | 49.45% | -1.06 | -1.11 | 2.80 | -10.43 |
| PRFX | PRF Technologies Ltd. | $2.97 | 239.18K | — | — | — | — | -0.02 | 0.15 | — | 0.27 | — | 0.15 | 0.00% | — | — | -321.92% | 948.79% | -201.84% | 0.02 | -1048.07 | 1.81 | 1.79 | 0.29 | -8123.00% | — | 8891.00% | -4551.60% | -5.17 | 816.94% | 0.00% | 0.00% | 0.00% | 0.27 | 0.31 | — | -27.58 |
| RDHL | RedHill Biopharma Ltd. | $0.97 | 3.23M | +40,100% | +30% | — | — | -0.94 | -1.66 | 0.97 | -0.46 | — | -0.76 | 60.31% | -181.69% | -102.80% | 632.60% | 242.32% | -40.24% | -0.08 | -265.69 | 0.54 | 0.37 | 0.56 | -11522.00% | 2317.00% | -7383.00% | -120.72% | -0.42 | 155.51% | 0.00% | 0.00% | 0.00% | -0.24 | -0.37 | 0.44 | -34.89 |
| SHPH | Shuttle Pharmaceuticals H… | $1.00 | 1.07M | — | — | — | — | -13.69 | 176.53 | — | -16.00 | -0.01 | 176.53 | 0.00% | — | — | -383.84% | 4303.31% | -216.24% | 1.65 | -5.66 | 1.44 | 1.25 | 0.10 | 21593171.00% | — | 3084.00% | -5.85% | -4.78 | 4097.02% | 0.00% | 0.00% | 0.00% | -16.17 | -16.98 | — | 12.67 |
| UPC | Universe Pharmaceuticals … | $2.72 | 1.53M | +5,735,314% | +242,398% | +399,145% | +515,984% | 0.00 | 0.00 | 0.00 | 8.32 | — | 0.00 | 35.28% | -16.33% | -20.56% | -7.23% | -10.45% | -5.35% | 0.16 | -12.57 | 4.07 | 3.55 | 8.33 | -2649.00% | -2244.00% | -4529.00% | -37140.54% | -0.38 | -19.36% | 0.00% | 0.00% | 19477.17% | 8.34 | 4.50 | -1.36 | 0.54 |
About Akanda Corp.
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
- CEO
- Katharyn Field
- Employees
- 46
- Beta
- 1.69
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($10.00 ÷ $57.09) − 1 = -82.48% (DCF, example).